ArticlePreventive medicine reports2025
Older adults' interest and concerns about life expectancy information for cancer screening decisions: Results from the National Poll on Healthy Aging.
Article in Preventive medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Medical Maximizing Tendencies and Acceptance of Life Expectancy-Based Cancer Screening.JAMA network open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Life expectancy is a more nuanced metric than age by which to weigh the risks, harms, and benefits of different preventive care tests and interventions. This study characterized older adults' attitudes and beliefs regarding life expectancy information and the acceptability of its use in decisions about cancer screening. Methods: Data were collected in January 2023 as part of the University of Michigan National Poll on Healthy Aging, a recurring, nationally representative household survey of adults in the United States. Results: Respondents were 1298 older adults ages 65 to 80 years (mean age = 70.9; 675 [52 %] male, 754 [58 %] White). Although 61.3 % of respondents were interested in knowing their life expectancy and 62.3 % believed knowing how much longer they are likely to live would help them make better health decisions, very few (4.5 %) had ever discussed their life expectancy with a provider. Older adults found it more acceptable for a provider to bring up life expectancy when recommending continuing (85.6 %) than stopping cancer screening (47.2 %). More men than women were interested in knowing their life expectancy (66.5 % vs. 56.9 %, Conclusions: Most older adults were interested in knowing their estimated life expectancy, but few are having conversations about it with healthcare providers or to inform cancer screening decisions. Further efforts are needed to improve patient-provider consideration of and discussion about life expectancy as a component of informed medical decision making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.